SCHEMBL6288516

SCHEMBL6288516

CCOC(=O)c1c(-c2cccc(F)c2)nc2c(cnn2C)c1NNc1ccc(Cl)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR2 O95136 4/20 0.39
ALDH1A2 O94788 1/20 0.39
ALDH1A3 P47895 1/20 0.39
CSNK1D P48730 1/20 0.39
JAK2 O60674 1/20 0.39
JAK3 P52333 1/20 0.39
TRPM8 Q7Z2W7 1/20 0.38
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 2/20 0.38
HSD17B10 Q99714 1/20 0.38
DHODH Q02127 1/20 0.38
HTR2C P28335 1/20 0.37
GPBAR1 Q8TDU6 1/20 0.37
P2RX3 P56373 1/20 0.37
GAA P10253 2/20 0.37
MAPT P10636 2/20 0.37
MEN1 O00255 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2C9 P11712 1/20 0.37
HPGD P15428 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6288518 0.82 SMN1; SMN2 (0.40) S1PR2ALDH1A2ALDH1A3TRPM8KDM4E
SCHEMBL6701828 0.73 KDM4E (0.49) CSNK1DKDM4EALDH1A1HSD17B10GPBAR1
SCHEMBL6288517 0.72 ALDH1A1 (0.42) CSNK1DJAK2JAK3TRPM8KDM4E
SCHEMBL6288769 0.71 MAPT (0.39) S1PR2KDM4EALDH1A1HSD17B10MAPT
SCHEMBL16877267 0.68 JAK2 (0.49) CSNK1DJAK2JAK3TRPM8KDM4E
SCHEMBL21268560 0.67 CSNK1D (0.49) CSNK1DJAK2JAK3TRPM8KDM4E
SCHEMBL20028187 0.67 JAK2 (0.55) CSNK1DJAK2JAK3TRPM8KDM4E
SCHEMBL6290563 0.65 ALDH1A1 (0.57) KDM4EALDH1A1HSD17B10GAAMAPT
SCHEMBL14640582 0.65 MAPT (0.58) CSNK1DTRPM8KDM4EALDH1A1DHODH
SCHEMBL28477674 0.64 ADORA2B (0.58) CSNK1DJAK2JAK3TRPM8KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6900223-B2 Dihydrodipyrazolopyridinone inhibitors of B7-1 WYETH (US) 2005-05-31 US disclosed
US-20040044024-A1 Dihydrodipyrazolopyridinone inhibitors of B7-1 WYETH (US) 2004-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040044024-A1 Dihydrodipyrazolopyridinone inhibitors of B7-1 CD274, PDCD1, PDCD1LG2 S1PR2 691/4885ALDH1A2 465/4885ALDH1A3 852/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.